Harald Hugenschmidt

Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.

Joachim Drevs, Ilse Hofmann, Harald Hugenschmidt et al. · PubMed · 2000 · 309 citations

Medicine, Oncology, Pharmacology +17

PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging.

Joachim Drevs, Ralph Müller-Driver, Christine Wittig et al. · PubMed · 2002 · 204 citations

Medicine, Oncology, Pharmacology +17

Urinary levels of monocyte chemo‐attractant protein‐1 correlate with tumour stage and grade in patients with bladder cancer

Amann, Perabo, Wirger et al. · British Journal of Urology · 1998 · 89 citations

Medicine, Immunology, Oncology +17

Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer

Stalin Chellappa, Harald Hugenschmidt, Morten Hagness et al. · OncoImmunology · 2015 · 70 citations · Full text

Medicine, Immunology, Oncology +17

Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival

Lars Thomas Seeberg, Anne Waage, Cathrine Brunborg et al. · Annals of Surgery · 2014 · 62 citations

Medicine, Oncology, Surgery +17